Skip to content

Observational Study on treatment status and adherence in patients with Bipolar disorder Using claims database in Japan.

Observational Study on treatment status and adherence in patients with Bipolar disorder Using claims database in Japan. - Observational Study on treatment status and adherence in patients with Bipolar disorder Using claims database in Japan.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000041304
Enrollment
14000
Registered
2020-08-10
Start date
2020-04-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar disorder

Interventions

None listed

Sponsors

Otsuka Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Meeting all of the following criteria 1)Patients who started treatment for bipolar disorder for 365 days from the Index date. 2)Aged 18 years and older at the time of the index date 3)Patients who have not withdrawn insurance for 365 days from the Index date

Exclusion criteria

Exclusion criteria: Patients who meet the following 1)Patients who started treatment for Schizophrenia, dementia, autism and ADHD during the enrollment period. 2)Patients who started treatment for bipolar disorder or started treatment with target drug for bipolar disorder for 365 days from the Index date.

Design outcomes

Primary

MeasureTime frame
Proportion of Days Covered (PDC)

Countries

Japan

Contacts

Public ContactHiromi Sano

Otsuka Pharmaceutical Co., Ltd. Medical Affairs Department

sanoh@otsuka.jp06-6943-7722

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026